Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Clinical trial NCT02422498 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02422498
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-14
- Primary completion
- 2022-12-19
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.